Cytek Biosciences (CTKB) Other Operating Expenses (2020 - 2026)

Cytek Biosciences' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• Quarterly Other Operating Expenses fell 6.9% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.4 million (down 9.52% YoY) and the FY2025 annual result came in at $36.5 million, down 25.75% from the prior year.
• Other Operating Expenses was $11.6 million for Q1 2026 at Cytek Biosciences, up from $9.0 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $14.4 million in Q2 2023 and bottomed at $8.0 million in Q1 2022.
• A 5-year average of $10.9 million and a median of $11.6 million in 2026 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses surged 87.63% — and 2025, when it dropped 24.52%.
• Cytek Biosciences' Other Operating Expenses stood at $9.0 million in 2022, then advanced by 20.38% to $10.9 million in 2023, then gained by 9.25% to $11.9 million in 2024, then declined by 24.52% to $9.0 million in 2025, then rose by 29.95% to $11.6 million in 2026.
• Business Quant data shows CTKB's Other Operating Expenses at $11.6 million in Q1 2026, $9.0 million in Q4 2025, and $11.7 million in Q3 2025.